Low-Grade Hepatic Steatosis Is Associated with Long-term Remission of Type 2 Diabetes Independent of Type of Bariatric-Metabolic Surgery.
Anne LautenbachMarie WerneckeOliver MannJonas WagnerStefan WolterFabian StollJens AberlePublished in: Obesity surgery (2022)
Our results suggest that the presence of low-grade liver steatosis is associated with remission of T2D following sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB). Therefore, BS should be considered at an early NAFLD stage in patients with T2D.
Keyphrases
- low grade
- roux en y gastric bypass
- type diabetes
- weight loss
- gastric bypass
- high grade
- disease activity
- obese patients
- insulin resistance
- minimally invasive
- ulcerative colitis
- coronary artery bypass
- glycemic control
- bariatric surgery
- systemic lupus erythematosus
- cardiovascular disease
- surgical site infection
- metabolic syndrome
- skeletal muscle
- coronary artery disease
- atrial fibrillation
- liver fibrosis